Measuring the number of influenza-associated events prevented by influenza vaccination among the elderly in the European Union would allow a better understanding of the overall impact of influenza vaccination programmes, particularly in seasons with low influenza vaccine effectiveness (IVE). This study measured the number of medically attended influenza-confirmed cases in primary care (MAICC) among those ≥65 years averted by influenza vaccination programmes in Spain (SP), the Netherlands (NL) and Portugal (PT), from 2015 to 2018.The IMOVE+ project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634446.N/
Objectives: The aim of the EVA Hospital study was to measure IVE against influenza laboratory confir...
The DRIVE project aims to establish a sustainable network to estimate brand-specific influenza vacci...
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. I...
Measuring the number of influenza-associated events prevented by influenza vaccination among the eld...
To increase the acceptability of influenza vaccine, it is important to quantify the overall benefits...
BackgroundTo increase the acceptability of influenza vaccine, it is important to quantify the overal...
Every year the influenza vaccine is reformulated,so estimating the influenza vaccine effectiveness (...
BackgroundTo increase the acceptability of influenza vaccine, it is important to quantify the overal...
In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A...
We conducted a multicentre test-negative case-control study in 27 hospitals of 11 European countries...
We conducted a multicentre test-negative case–control study in 27 hospitals of 11 European countries...
We conducted a multicentre test-negative case-control study in 27 hospitals of 11 European countries...
All aged individuals with a chronic condition and those with 65 and more years are at increased risk...
Within I-MOVE (European programme to monitor seasonal and pandemic influenza vaccine effectiveness (...
In Europe, annual influenza vaccination is recommended to elderly. From 2011 to 2014 and in 2015-16,...
Objectives: The aim of the EVA Hospital study was to measure IVE against influenza laboratory confir...
The DRIVE project aims to establish a sustainable network to estimate brand-specific influenza vacci...
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. I...
Measuring the number of influenza-associated events prevented by influenza vaccination among the eld...
To increase the acceptability of influenza vaccine, it is important to quantify the overall benefits...
BackgroundTo increase the acceptability of influenza vaccine, it is important to quantify the overal...
Every year the influenza vaccine is reformulated,so estimating the influenza vaccine effectiveness (...
BackgroundTo increase the acceptability of influenza vaccine, it is important to quantify the overal...
In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A...
We conducted a multicentre test-negative case-control study in 27 hospitals of 11 European countries...
We conducted a multicentre test-negative case–control study in 27 hospitals of 11 European countries...
We conducted a multicentre test-negative case-control study in 27 hospitals of 11 European countries...
All aged individuals with a chronic condition and those with 65 and more years are at increased risk...
Within I-MOVE (European programme to monitor seasonal and pandemic influenza vaccine effectiveness (...
In Europe, annual influenza vaccination is recommended to elderly. From 2011 to 2014 and in 2015-16,...
Objectives: The aim of the EVA Hospital study was to measure IVE against influenza laboratory confir...
The DRIVE project aims to establish a sustainable network to estimate brand-specific influenza vacci...
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. I...